Annals of Surgical Oncology

OCT 21, 2026 · JOURNAL ARTICLE

The Landmark Series: Perioperative Management of Hepatocellular Carcinoma

Annals of Surgical Oncology

Abstract Background Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with an increasing burden of metabolic dysfunction-associated stea

OCT 20, 2026 · JOURNAL ARTICLE

Androgen Receptor (AR) Expression is Associated with an Immune-Cold Phenotype and Reduced Response to Immune Checkpoint Inhibitors in ER-Positive/HER2-Negative Breast Cancer

Annals of Surgical Oncology

Abstract Background Immune checkpoint inhibitors (ICIs) have limited efficacy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2-) breast can

OCT 13, 2026 · JOURNAL ARTICLE

Predictive Factors for Occult Metastases in Clinically M0 Pancreatic Cancer: A Prospective Multicenter Analysis of Staging Laparoscopy

Annals of Surgical Oncology

Abstract Background Staging laparoscopy (SL) is a minimally invasive approach for detecting occult metastases in patients with pancreatic cancer (PC) without signs of metastasis on

OCT 12, 2026 · JOURNAL ARTICLE

Primary Breast Angiosarcoma: Clinicopathologic Features and Oncologic Outcomes

Annals of Surgical Oncology

Abstract Background Primary breast angiosarcoma (PBA) is rare, and limited data exist because studies often combine primary and secondary angiosarcoma patients. Methods For patient

OCT 12, 2026 · JOURNAL ARTICLE

Clinical Efficacy of Tislelizumab Plus Gemcitabine-Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer and Chemoresistance Analysis: A Prospective Pilot Study

Annals of Surgical Oncology

Abstract Background Neoadjuvant therapy can improve the survival outcomes of patients with borderline resectable pancreatic cancer (BRPC). However, standard neoadjuvant regimens re

OCT 6, 2026 · JOURNAL ARTICLE

Financial Toxicity in Patients with Resected Esophageal Cancer

Annals of Surgical Oncology

Abstract Background Esophagectomy for esophageal cancer is associated with significant morbidity and can result in financial hardship, yet this aspect of survivorship remains under

SEP 29, 2026 · JOURNAL ARTICLE

Next-Generation Sequencing Identifies Key Targetable Mutations in the Treatment of Appendiceal Neoplasms

Annals of Surgical Oncology

Abstract Background Appendiceal neoplasms are a group of rare, heterogeneous tumors that exhibit varying malignant potential. Systemic treatment options for disseminated appendicea

SEP 25, 2026 · JOURNAL ARTICLE

Systemic Chemotherapy in Patients with Synchronous Peritoneal Metastasis from Gastric and Esophagogastric Junction Cancers Has No Uniform Effect on the Peritoneal Cancer Index

Annals of Surgical Oncology

Abstract Background The prognosis of patients with peritoneal metastasis (PM) from gastric cancer or adenocarcinoma of the esophagogastric junction (EGJ) remains poor. Diagnostic l